Scarica l'app Stockscreener
60.70
1.56%
0.93
Precedente Chiudi:
$59.77
Aprire:
$60.27
Volume 24 ore:
34,822
Relative Volume:
0.50
Capitalizzazione di mercato:
$229.97M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+7.36%
1M Prestazione:
+11.68%
6M Prestazione:
+24.92%
1 anno Prestazione:
+54.73%
Intervallo 1D:
$60.05
$60.73
Intervallo di 1 settimana:
$56.77
$60.73
Portata 52W:
$38.95
$60.73
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Nome
State Street Spdr S P Pharmaceuticals Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
60.70 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
361.86 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
733.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
737.41 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
290.85 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
695.77 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Borsa (XPH) Ultime notizie
7 ETFs to Play a Healthcare Stock Rebound - Barron's
Healthcare Is Due for a Rebound. These ETFs Are a Good Way to Buy In. - Barron's
Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026 - 24/7 Wall St.
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Why Is Organon Stock Skyrocketing Monday? - Benzinga
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0610 - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
State Street SPDR S&P Pharmaceuticals ETF (XPH) Stock Price, Holdings, Dividend Yield - GuruFocus
ETFs Investing in Recursion Pharmaceuticals, Inc. Class A Stocks - TradingView
Why Is Amneal Pharmaceuticals Stock Gaining Today? - Sahm
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now - 24/7 Wall St.
XPH ETF | State Street SPDR S&P Pharmaceuticals ETF - GuruFocus
XPH | State Street SPDR S&P Insider Trading - Quiver Quantitative
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Database
Stock Market Research, Data and Tools - GuruFocus
Is State Street SPDR S&P Emerging Markets Dividend ETF (EDIV) a Strong ETF Right Now? - Yahoo Finance
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended December 31, 2025 - marketscreener.com
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
Stock Market Today: Dow, S&P 500 Futures Drop Ahead Of Trump's 'Power Plant Day' Deadline— UnitedHealth - Benzinga
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
The Trader: Biotechs Are a Healthy Growth Bet. Thank M&A and New Drugs. -- Barron's - 富途牛牛
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 24/7 Wall St.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Vanguard Global Government Bond (VGGF.AS) Holdings - Yahoo! Finance Canada
No deal yet? Trump readies new tariffs on select drugmakersreport (SPY:NYSEARCA) - Seeking Alpha
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda - Benzinga
Top Pfizer Shareholders - Investopedia
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs - Barron's
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance - 24/7 Wall St.
The 1-Minute Market Report, March 29, 2026 (NYSEARCA:SPY) - Seeking Alpha
KRE: Valuations Are Declining, But May Not Correct Soon (NYSEARCA:KRE) - Seeking Alpha
EU officials say Iran war raising risk of stagflation (SPY:NYSEARCA) - Seeking Alpha
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investor Concerns Linger Amid Middle East Conflict - Moomoo
Chart Of The Day: What Will Oil Stocks Do If Oil Goes Vertical? - Seeking Alpha
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
XMHQ Struggles To Earn Market-Beating Returns, Consider Alternatives (NYSEARCA:XMHQ) - Seeking Alpha
Merck Preps for End of Keytruda Exclusivity with $6.7B Deal for Leukemia Treatment - The Daily Upside
ValuEngine Weekly Market Summary And Commentary - Seeking Alpha
IAK: Understanding The Structure And Suitability Of This Insurance ETF (NYSEARCA:IAK) - Seeking Alpha
Wall Street Lunch: Markets Seesaw After Trump’s Iran Pivot (undefined:SPY) - Seeking Alpha
Top performing semiconductor ETFs YTD, as sector rises on signals of war de-escalation (SMH:NASDAQ) - Seeking Alpha
Citi's large-cap stocks with negative ROE trends - Seeking Alpha
SA Asks: What can Congress do to protect Social Security benefits? - Seeking Alpha
State Street Spdr S P Pharmaceuticals Etf Azioni (XPH) Dati Finanziari
Non sono disponibili dati finanziari per State Street Spdr S P Pharmaceuticals Etf (XPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):